Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Tecadenoson

🥰Excellent
Catalog No. T17023Cas No. 204512-90-3
Alias CVT-510

Tecadenoson (CVT-510) is a selective A1 adenosine receptor agonist.

Tecadenoson

Tecadenoson

🥰Excellent
Purity: 99.76%
Catalog No. T17023Alias CVT-510Cas No. 204512-90-3
Tecadenoson (CVT-510) is a selective A1 adenosine receptor agonist.
Pack SizePriceAvailabilityQuantity
1 mg$46In Stock
5 mg$118In Stock
10 mg$188In Stock
25 mg$323In Stock
50 mg$457In Stock
100 mg$592In Stock
200 mg$783In Stock
1 mL x 10 mM (in DMSO)$130In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Tecadenoson"

Select Batch
Purity:99.76%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Tecadenoson (CVT-510) is a selective A1 adenosine receptor agonist.
In vitro
Tecadenoson is approximately 5 fold more potent to prolong the stimulus-to-His bundle (S-H interval), a measure of slowing AV nodal conduction (EC50=41?nM) than to increase coronary conductance (EC50=200?nM) in the atrial-paced isolated heart. Tecadenoson shortens atrial (EC50=73?nM) but not the ventricular monophasic action potentials (MAP). At concentrations of Tecadenoson (40?nM) and diltiazem (1?μM) that induces equal prolongation of S-H interval (~10?ms), diltiazem, but not Tecadenoson, significantly decreases left ventricular developed pressure (LVP) and markedly increases coronary conductance [1].
In vivo
Intravenous infusions of Tecadenoson and diltiazem causes nearly equal prolongations of P-R interval In atrial-paced anaesthetized guinea-pigs. Tecadenoson (2, 5, 20 μg/kg i.p.) causes a rapid and sustained dose-dependent decrease in NEFA at doses that do not cause bradycardia. Tecadenoson (50 μg/kg) treatment induces a significant bradycardia (50% decrease in heart rate at 25 min) [1][2].
AliasCVT-510
Chemical Properties
Molecular Weight337.33
FormulaC14H19N5O5
Cas No.204512-90-3
SmilesOC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N[C@@H]3CCOC3)ncnc12
Relative Density.1.89g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 155 mg/mL (459.49 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.9645 mL14.8223 mL29.6446 mL148.2228 mL
5 mM0.5929 mL2.9645 mL5.9289 mL29.6446 mL
10 mM0.2964 mL1.4822 mL2.9645 mL14.8223 mL
20 mM0.1482 mL0.7411 mL1.4822 mL7.4111 mL
50 mM0.0593 mL0.2964 mL0.5929 mL2.9645 mL
100 mM0.0296 mL0.1482 mL0.2964 mL1.4822 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Tecadenoson | purchase Tecadenoson | Tecadenoson cost | order Tecadenoson | Tecadenoson chemical structure | Tecadenoson in vivo | Tecadenoson in vitro | Tecadenoson formula | Tecadenoson molecular weight